Windlas Biotech Limited (NSE:WINDLAS)
India flag India · Delayed Price · Currency is INR
971.00
+14.80 (1.55%)
May 22, 2025, 3:29 PM IST

Windlas Biotech Company Description

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally.

The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms.

It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids.

Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.

Windlas Biotech Limited
Country India
Founded 2001
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,154
CEO Komal Gupta

Contact Details

Address:
705-706, Vatika Professional Point
Gurugram, Haryana 122001
India
Phone 91 12 4282 1030
Website windlas.com

Stock Details

Ticker Symbol WINDLAS
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE0H5O01029
SIC Code 2834

Key Executives

Name Position
Komal Gupta Chief Financial Officer and Chief Executive Officer
Ananta Narayan Panda Company Secretary and Compliance Officer
Ashok Kumar Windlass Whole-Time Director
Hitesh Windlass MD and Executive Director
Manoj Kumar Windlass Joint MD and Executive Director
Pawan Kumar Sharma Executive Director
Mohammed Aslam President of Sales and Marketing
Om Prakash Sule Site Quality Head